Cholestenone 5 alpha-Reductase
"Cholestenone 5 alpha-Reductase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An oxidoreductase that catalyzes the conversion of 3-oxo-delta4 steroids into their corresponding 5alpha form. It plays an important role in the conversion of TESTOSTERONE into DIHYDROTESTOSTERONE and PROGESTERONE into DIHYDROPROGESTERONE.
| Descriptor ID |
D042944
|
| MeSH Number(s) |
D08.811.682.660.200
|
| Concept/Terms |
Cholestenone 5 alpha-Reductase- Cholestenone 5 alpha-Reductase
- 5 alpha-Reductase, Cholestenone
- Cholestenone 5 alpha Reductase
- alpha-Reductase, Cholestenone 5
- 4-Ene Steroid 5 alpha-Reductase
- 4 Ene Steroid 5 alpha Reductase
- 5 alpha-Reductase
- 5 alpha Reductase
|
Below are MeSH descriptors whose meaning is more general than "Cholestenone 5 alpha-Reductase".
Below are MeSH descriptors whose meaning is more specific than "Cholestenone 5 alpha-Reductase".
This graph shows the total number of publications written about "Cholestenone 5 alpha-Reductase" by people in this website by year, and whether "Cholestenone 5 alpha-Reductase" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cholestenone 5 alpha-Reductase" by people in Profiles.
-
Inhibition of 5alpha-reductase enhances testosterone-induced expression of U19/Eaf2 tumor suppressor during the regrowth of LNCaP xenograft tumor in nude mice. Prostate. 2010 Oct 01; 70(14):1575-85.
-
Current role for combination therapy in male LUTS. Arch Esp Urol. 2010 Jun; 63(5):323-32.
-
Effects of finasteride (MK-906), a 5 alpha-reductase inhibitor, on circulating androgens in male volunteers. J Clin Endocrinol Metab. 1990 Apr; 70(4):1136-41.
-
Discrimination between normal, hyperplastic and malignant human prostatic tissues by enzymatic profiles. J Urol. 1985 Mar; 133(3):495-501.